Search company, investor...

Stage

Loan | IPO

Total Raised

$129.29M

Market Cap

0.00B

Stock Price

5.45

Revenue

$0000 

About Avinger

Avinger is a commercial-stage medical device company operating in the healthcare sector. The company designs, manufactures, and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD), a condition characterized by plaque build-up in the arteries that supply blood to the arms and legs. Avinger's products are based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. It is based in Redwood City, California.

Headquarters Location

400 Chesapeake Drive

Redwood City, California, 94063,

United States

650-363-2400

Loading...

Loading...

Avinger Patents

Avinger has filed 81 patents.

The 3 most popular patent topics include:

  • medical equipment
  • vascular procedures
  • interventional radiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/4/2021

2/20/2024

Fiber optics, Optical fiber, Catheters, Medical equipment, Implants (medicine)

Grant

Application Date

10/4/2021

Grant Date

2/20/2024

Title

Related Topics

Fiber optics, Optical fiber, Catheters, Medical equipment, Implants (medicine)

Status

Grant

Latest Avinger News

Avinger jumps 28%, enters ATM equity offering

Sep 19, 2023

EXTREME-PHOTOGRAPHER Microcap pharma device manufacturer Avinger (NASDAQ: AVGR ) stock price jumped 28% during post-market hours on Monday after having touched the peak of $11.18 on the same day. The company entered into an agreement as a sales agent to offer shares initially up to an aggregate offering price of $7M at-the-market public offering. On August 3, 2022, the company determined to suspend sales under the ATM agreement and terminated the $7M offering. In March 2023, however, the company determined to resume sales under the ATM agreement, up to an aggregate offering price of ~$1.15M. The company has determined to increase the amount available for sale under the ATM agreement to an additional aggregate offering price of ~$2.13M. The total number of shares to be sold and the proceeds thereafter remain unclear. The company expects to use any net proceeds primarily for working capital and general corporate purposes, as well as for the research of lumivascular platform products, preclinical and clinical trials and studies, regulatory submissions, expansion of its sales and marketing organizations and efforts, intellectual property protection and enforcement, and capital expenditures.

Avinger Frequently Asked Questions (FAQ)

  • Where is Avinger's headquarters?

    Avinger's headquarters is located at 400 Chesapeake Drive, Redwood City.

  • What is Avinger's latest funding round?

    Avinger's latest funding round is Loan.

  • How much did Avinger raise?

    Avinger raised a total of $129.29M.

  • Who are the investors of Avinger?

    Investors of Avinger include Paycheck Protection Program and Lucas Venture Group.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.